seewhy
reacted to
seewhy
commented on
$Maxeon Solar Technologies (MAXN.US)$ Any issue with 13 dollars today?
1
seewhy
liked
$Maxeon Solar Technologies (MAXN.US)$ Expecting for it to reach 23.00. It did run out of shares today.
9
1
seewhy
liked
2
4
seewhy
liked
$Helport AI (HPAI.US)$Benzinga· 23 mins ago
Helport AI (NASDAQ:HPAI) reported quarterly earnings of $47.24 thousand per share. This is a 53.06 percent increase over earnings of $30.86 thousand per share from the same period last year. The company reported $29.58 million in sales this quarter. This is a 132.37 percent increase over sales of $12.73 million the same period last year.
Helport AI (NASDAQ:HPAI) reported quarterly earnings of $47.24 thousand per share. This is a 53.06 percent increase over earnings of $30.86 thousand per share from the same period last year. The company reported $29.58 million in sales this quarter. This is a 132.37 percent increase over sales of $12.73 million the same period last year.
6
seewhy
liked
$Palatin Technologies (PTN.US)$
Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
• Topline results expected in 1Q calendar year 2025
• Study is assessing the co-administration of bremelanotide and tirzepatide on reducing body weight
• Data will inform and support the Company's obesity programs using novel, long-acting and highly selective MC4R peptide and small molecule compoun...
Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
• Topline results expected in 1Q calendar year 2025
• Study is assessing the co-administration of bremelanotide and tirzepatide on reducing body weight
• Data will inform and support the Company's obesity programs using novel, long-acting and highly selective MC4R peptide and small molecule compoun...
2
seewhy
liked
$Psyence Biomedical (PBM.US)$ Press Release: Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs
Dow Jones· 1 min ago
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs
PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being
Psyence Biomedical has issued common shares to Psyence Group pursuant to ...
Dow Jones· 1 min ago
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs
PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being
Psyence Biomedical has issued common shares to Psyence Group pursuant to ...
4
2